Compositon/Ingredients: Ethambutol

Ethambutol is indicated in the treatment of primary and post– primary (reactivated) tuberculosis and it should be given in combination with other antituberculosis agents such as Isoniazid, Rifampicin, Streptomycin and Pyrazinamide in order to improve cure rates and reduce the emergence of drug– resistant tuberculosis.

– Hypersensitivity to any ingredient of the medicine.
– Optic neuritis.

This medicine should be used in conjunction with other anti– tuberculous drugs as prescribed by physicians.
Recommended dosage: a single oral dose in the morning, taken on a empty stomach. Adults and children ≥ 6 years:
15mg/kg, single once daily. Or intermittent dose 30mg/kg, 3 times weekly; or 45mg/kg, 2 times weekly.

– The dosage of Ethambutol should be adjusted appropriately in patients with renal dysfunction.
– The visual functions should be monitored, especially in children. If there is sign of visual side– effects the medication should be discontinued immediately. This medication is not recommended for children under 6 years of age.
– Ethambutol may cause or worsen attacks of gout.

Store at temperature below 30°C. Avoid direct sunlight and moisture.